Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

Elizabeth Marrett,1 Changgeng Zhao,1 Ning Jackie Zhang,2 Qiaoyi Zhang,1 Dena R Ramey,1 Joanne E Tomassini,1 Andrew M Tershakovec,1 David R Neff11Merck & Co, Inc., Whitehouse Station, NJ, USA; 2College of Health and Public Affairs, University of Central Florida, Orlando, FL, USABackground: G...

Full description

Bibliographic Details
Main Authors: Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR
Format: Article
Language:English
Published: Dove Medical Press 2014-04-01
Series:Vascular Health and Risk Management
Online Access:http://www.dovepress.com/limitations-of-real-world-treatment-with-atorvastatin-monotherapy-for--a16569

Internet

http://www.dovepress.com/limitations-of-real-world-treatment-with-atorvastatin-monotherapy-for--a16569

Similar Items